Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsFRA:UTM -2.50%73 EBITDA Margin % is 33.89% as of Jun. 2026, which is 33% below its 10-year median of 50.50. GuruFocus rates FRA:UTM with a GF Score™ of 73/100 and a GF Value™ of €49.20. The stock has 8 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Utah Medical Products ranks better than 93.12% on this metric.
Utah Medical Products (FRA:UTM) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Utah Medical Products EBITDA Margin % Related Terms
Utah Medical Products EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Utah Medical Products's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:UTM vs EMBC, SMTI, PDEX: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Utah Medical Products's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Utah Medical Products (FRA:UTM) has a EBITDA Margin % of 33.89% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Utah Medical Products and its competitors. This is 33% below median its historical median of 50.50. Over the past decade, Utah Medical Products' EBITDA Margin % has ranged from 36.46 to 53.34. According to the industry distribution chart, Utah Medical Products ranks #56 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is Utah Medical Products' EBITDA Margin % too high?
Utah Medical Products' current EBITDA Margin % of 33.89% is 33% below median its 10-year median of 50.50. Over the past 10 years, this metric has ranged from a low of 36.46 to a high of 53.34. The Medical Devices & Instruments industry median EBITDA Margin % is 8.08. Utah Medical Products' value of 33.89% is 319.4% above this industry median. Based on the distribution chart, Utah Medical Products ranks #56 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Utah Medical Products has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' EBITDA Margin % compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #56 out of 814 companies for EBITDA Margin %. This places Utah Medical Products in the top 7% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.08. Utah Medical Products' value of 33.89% is 319.4% above this benchmark. Historically, Utah Medical Products' own EBITDA Margin % has ranged from 36.46 to 53.34 over the past decade. While the company's 10-year median is 50.50 vs. the industry median of 8.08, Utah Medical Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 8.08, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current EBITDA Margin % of 33.89% is 319.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 8.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current EBITDA Margin % is 33.89%, which is 33% below median its own 10-year median of 50.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Utah Medical Products (FRA:UTM) has a current EBITDA Margin % of 33.89%. The stock's GF Value™ is €49.20, compared to a current price of €58.50 — trading 18.9% above its estimated fair value. The current EBITDA Margin % is 33.89%, which is 33% below median its 10-year median of 50.50 and 319.4% above the Medical Devices & Instruments industry median of 8.08. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Utah Medical Products (FRA:UTM), the current EBITDA Margin % is 33.89% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (FRA:UTM) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of €58.50 is trading 18.9% above its estimated GF Value™ of €49.20.
Key valuation signals for FRA:UTM:
EBITDA Margin %: 33.89% (33% below median its 10-year median of 50.50)
GF Value™: €49.20 vs. price of €58.50 (18.9% above fair value)
Industry Position: 319.4% above the Medical Devices & Instruments median (#56 of 814)
No single metric tells the full story. See the FRA:UTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for FRA:UTM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UTM has been successfully added to your 
